Tag: ADCs

All our news

We’re excited to share our upcoming presentations of two posters at the American Association for Cancer Research (AACR) Annual Meeting 2025, happening April 25-30 in Chicago, IL!

Xentech is willing to accelerate the preclinical development/validation of new anti-cancer therapeutics with a growing panel of highly predictive human tumor-based models and robust screening/profiling studies.

Looking forward to welcoming you at booth #538 or in front of the posters !

Discover

All our news

XenTech will be attending AACR Annual Meeting in San Diego (Apr. 5-10 2024)

Olivier, Vincent and Marie cordially invite you to stop by our Booth#3645 to discuss your innovative research projects.

Discover

All our news

ITCC-P4, first company in the world to offer preclinical drug tests for children with cancer

Discover

All our news

XenTech will attend AACR Annual Meeting in Orlando (Apr. 14-19 2023)

Philippe, Olivier and Delphine cordially invite you to stop by our Booth#618 to discuss our solid tumor PDX collection to bring your innovative research projects a step further !

Discover

All our news

XenTech will attend the World ADC London (Mar.- 13-16th)

Philippe and Olivier cordially invite you to stop by our Booth#12 to discuss our long experience in testing ADCs in our solid tumor PDX collection !

Discover